Published in Ther Umsch on August 01, 1980
[The HIV epidemic: the end of special status]. Rev Med Suisse Romande (1992) 2.45
[Factors determining the choice of a modality of treatment by dialysis: a study of nine dialysis centers]. Nephrologie (2000) 1.39
Impact of time-interval after transplantation and therapy with fibrates on serum cholesterol levels in renal transplant patients. Clin Nephrol (1993) 1.39
Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation (1997) 1.15
Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med (1977) 0.98
Percutaneous transluminal dilatation for restoration of angioaccess in chronic hemodialysis patients. Cardiovasc Intervent Radiol (1982) 0.93
Heroin associated nephropathy: clinical and histological studies in 19 patients. Clin Nephrol (1979) 0.91
The interpretation of abnormal sexchromatin incidence in human breast tumors on the basis of DNA measurements. Eur J Cancer (1968) 0.88
Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin. Antimicrob Agents Chemother (1986) 0.85
[Relationship between sex chromatin incidence, nuclear size and DNA content in breast tumors and its significance for the survuval rate]. Schweiz Med Wochenschr (1967) 0.84
Effects of glucocorticoid deficiency on renal medullary cyclic adenosine monophosphate of rats. Clin Sci Mol Med (1978) 0.84
[Proteinuria and kidney transplantation. A quantitative immunochemical study of 7 protein clearances during the first 50 days following implantation of cadaver kidney]. Schweiz Med Wochenschr (1977) 0.83
Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in patiens on maintenance hemodialysis. Clin Nephrol (1980) 0.82
[Cryptic miliary tuberculosis and pancytopenia]. Schweiz Med Wochenschr (1973) 0.82
[The therapeutic significance of plasmapheresis in immunologic diseases]. Schweiz Med Wochenschr (1981) 0.81
Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients. Antiviral Res (1983) 0.81
[2 cases of acute sickle cell crisis in subjects with sickle cell trait following high altitude exposure]. Schweiz Med Wochenschr (1989) 0.80
Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populations. Eur J Clin Microbiol (1984) 0.80
[Heavy chain disease. A case of IgG-heavy-chain-fragment and IgM-type K-paraproteinemia with plasma cell leukemia]. Schweiz Med Wochenschr (1970) 0.79
Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia. Int J Artif Organs (1986) 0.79
[The treatment of chronic bronchitis with trimethoprim-sulphamethoxazole (bactrim) a double-blind trial in comparison with epicillin (spectacillin) (author's transl)]. Schweiz Rundsch Med Prax (1979) 0.79
[The treatment of hyperuricemia after kidney transplantation]. Schweiz Med Wochenschr (1977) 0.78
[Osteomalacia due to a long-term antiepileptic treatment]. Schweiz Med Wochenschr (1972) 0.78
Serum immunoglobulin levels and natural antibodies to Haemophilus influenzae in hemodialysis patients: evidence for IgG subclass imbalances. Nephron (1990) 0.77
Effect of unilateral obstruction on renal cell metabolism and function. J Lab Clin Med (1978) 0.77
Does blood transfusion induce a nonspecific suppression of cell-mediated immunity? Transplant Proc (1982) 0.76
Six-month overnight administration of intraperitoneal amino acids does not improve lean mass. Clin Nephrol (1996) 0.76
Erythrocyte deformability in dialysed and non-dialysed uraemic patients. Eur J Clin Invest (1982) 0.76
[The problem of hemoperfusion in poisonings: ineffectiveness in maprotiline poisoning]. Schweiz Med Wochenschr (1980) 0.76
Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis. J Bone Miner Res (1996) 0.75
[AIDS. Response to the letter by P. Kammerlander et al. on the subject of our article: HIV epidemic: the end of a special law?]. Rev Med Suisse Romande (1992) 0.75
[Possibilities in the treatment of hypertension with beta-blockaders]. Schweiz Rundsch Med Prax (1972) 0.75
Pharmacokinetics of tenoxicam in patients with impaired renal function. Eur J Clin Pharmacol (1986) 0.75
Rapidly progressive glomerulonephritis accompanying Legionnaires' disease. Arch Intern Med (1985) 0.75
[Osteoporosis and osteomalacia]. Schweiz Med Wochenschr (1975) 0.75
[Selective elimination of atherogenic lipoproteins using dextran-sulfate cellulose. Experiences in 2 patients with heterozygote familial hypercholesterolemia]. Schweiz Med Wochenschr (1989) 0.75
[Influenza vaccination in dialysis patients]. Schweiz Med Wochenschr (1978) 0.75
[Home hemodialysis]. Rev Med Suisse Romande (1973) 0.75
[Certain and disputed indications of immunosuppressive therapy in kidney diseases]. Schweiz Med Wochenschr (1978) 0.75
Paramyotonia congenita. A clinical, electrophysiological and histological study of 12 patients. J Neurol (1979) 0.75
[Toxicity of an organic Germanium compound: deleterious consequences of a "natural remedy"]. Schweiz Med Wochenschr (1992) 0.75
Prediction of the histological type of glomerulonephritis. Multiple discriminant analysis of clinical and laboratory characteristics at time of diagnosis. Nephron (1980) 0.75
[Epileptic seizures and myoclonus in kidney failure]. Schweiz Rundsch Med Prax (1983) 0.75
[Haemofiltration (author's transl)]. Ther Umsch (1982) 0.75
[Antigenicity of various depot insulin drugs for diabetics]. Helv Med Acta Suppl (1970) 0.75
[Continuous ambulatory peritoneal dialysis, advantages and disadvantages]. Schweiz Med Wochenschr (1981) 0.75
[Home dialysis]. Ther Umsch (1989) 0.75
Human recombinant erythropoietin in anaemic patients on maintenance haemodialysis. Secondary effects of the increase of haemoglobin. Nephrol Dial Transplant (1988) 0.75
[The intercantonal drug control office at the service of physicians]. Ther Umsch (1982) 0.75
Dysproteinaemia during total fasting. Metabolism (1979) 0.75
[Activation of the complement system in different forms of glomerulonephritis]. Schweiz Med Wochenschr (1977) 0.75
[Malignant non-Hodgkin's lymphoma with visual disorders and nephrotic syndrome]. Schweiz Med Wochenschr (1982) 0.75
[Immunologic bases of glomerulonephritis]. Ther Umsch (1982) 0.75
Changes in renal function induced by endralazine, a new antihypertensive drug. Eur J Clin Pharmacol (1983) 0.75
[Determination of fructosamine in chronic kidney diseases (dialysis-dependent patients)]. Wien Klin Wochenschr Suppl (1990) 0.75
[Hepatitis B vaccination]. Schweiz Med Wochenschr (1984) 0.75
[Diabetic nephropathy]. Schweiz Rundsch Med Prax (1986) 0.75
[Relations between plasma creatinine and glomerular filtrate determined by means of 2 different methods (Bonsnes-Taussky and Greiner analyzer II)]. Schweiz Med Wochenschr (1974) 0.75
[Single-needle hemodialysis]. Schweiz Med Wochenschr (1975) 0.75
[Treatment of chronically recurring urinary tract infection with trimethoprim sulfamethoxazole (Eusaprim)]. Schweiz Med Wochenschr (1970) 0.75
Impact of dialysis modality on body composition in patients with end-stage renal disease. Clin Nephrol (1992) 0.75
[Possibilities of the therapy of hypertension with beta blockaders]. Schweiz Rundsch Med Prax (1972) 0.75
[Metabolic compromise following reconstruction of the arterial circulation in severe muscle ischemia]. Helv Chir Acta (1984) 0.75
[Mineral content of the skeleton in chronic kidney insufficiency treated with dialysis and after kidney transplantation. Results of isotope densitometry]. Schweiz Med Wochenschr (1977) 0.75
[Exchangeable body calcium and carbohydrate tolerance in chronic uremia]. Helv Med Acta Suppl (1969) 0.75
[Treatment possibilities for the diabetic with advanced renal insufficiency]. Ther Umsch (1983) 0.75
[Complement and alpha l-antitrypsin after renal transplantation]. J Urol Nephrol (Paris) (1977) 0.75
[Diagnosis of kidney diseases]. Z Krankenpfl (1973) 0.75
Complement components, degradation products and immune complexes after kidney transplantation. Proc Eur Dial Transplant Assoc (1978) 0.75
[Infection susceptibility during thoracic duct drainage. Therapy of severe pyocyaneous infections with carbenicillin]. Schweiz Rundsch Med Prax (1971) 0.75
[Does the transplant of a transfused cadaver donor function better than one from a non-transfused donor?]. Helv Chir Acta (1984) 0.75
Treatment of type IIa and type V hyperlipoproteinemia and of a normal volunteer by continuous LDL-apheresis. Prog Clin Biol Res (1988) 0.75
Role of cyclic AMP in the natriuresis of extracellular fluid volume expansion in the dog. Clin Sci Mol Med (1977) 0.75
Role of immune complexes in pathogenesis of renal disease. Immunol Lett (1987) 0.75
[Heavy chain disease. A case of IgG-heavy-chain-fragment and IgM-type-K-paraproteinemia with plasma cell leukemia]. Helv Med Acta Suppl (1970) 0.75
[Primary retroperitoneal seminoma--a rare germ cell neoplasm]. Praxis (Bern 1994) (2000) 0.75
[Buccal oxytocin sensitivity test with desaminooxytocin]. Gynaecologia (1968) 0.75
[Acute combined alpha- and beta-adrenergic blockade in essential hypertension: effects on blood pressure, renal function, renin, and aldosterone]. Klin Wochenschr (1979) 0.75
[Disorders of the heart rhythm]. Ther Umsch (1972) 0.75
[Current therapy of nephrotic syndrome]. Schweiz Med Wochenschr (1984) 0.75
[Non-steroidal antirheumatic agents and nephrotoxicity]. Dtsch Med Wochenschr (1985) 0.75
[Plasma exchange in glomerulonephritis ]. Ther Umsch (1982) 0.75
Normal levels of allo- but increased levels of potentially autoreactive antibodies against ABO histo-blood group antigens in AIDS patients. Clin Immunol Immunopathol (1996) 0.75
[Sexchromatin findings and the clinical course of breast carcinoma]. Helv Chir Acta (1968) 0.75
[Derivatives of vitamin d: basic considerations and therapeutic applications (author's transl)]. Ther Umsch (1979) 0.75
[Serum ferritin in renal insufficiency, hemodialysis and kidney transplantation]. Schweiz Med Wochenschr (1978) 0.75
Factor VIII activity in chronic renal disease. Nephron (1981) 0.75
[Comparison of the average flow time and renal glow as measured in man using 2 indicators: indocyanine and erythrocytes marded with 99mTc]. J Urol Nephrol (Paris) (1975) 0.75
Effect of calcium-channel blockers on calcium-phosphate metabolism in patients with end-stage renal disease. Nephrol Dial Transplant (1996) 0.75
[On the problem of gamma globulin therapy of infectious diseases. Passive mice immunity studies with human gamma globulin]. Helv Med Acta (1965) 0.75
[Changes in serum concentrations of calcium and inorganic phosphates and alkaline phosphatase activity due to anti-ipileptic treatment]. Schweiz Med Wochenschr (1976) 0.75
Lipoprotein changes in familial hypercholesterolemia after extracorporeal immunoadsorption of low density lipoproteins. Ann Biol Clin (Paris) (1988) 0.75
[Immunosuppressive therapy of nephropathies (author's transl)]. Ther Umsch (1979) 0.75
[Thrombocytopenia in Waldenstrom's disease with specific antithrombocytic properties of the IgM paraprotein]. Schweiz Med Wochenschr (1975) 0.75
[Management of hypercholesteremia by extracorporeal immune adsorption]. Schweiz Med Wochenschr (1986) 0.75
[Bone disease in patients with chronic renal failure and during long-term hemodialysis]. Ther Umsch (1972) 0.75
[Composition of the urine of patients with terminal renal failure before and after treatment with hemodialysis]. Schweiz Med Wochenschr (1977) 0.75
[Kidney diseases and hypertension in pregnancy]. Ther Umsch (1987) 0.75